Salon, Albern C.
HRN: 01-62-66 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/17/2025
METRONIDAZOLE 500MG (TAB)
01/17/2025
01/31/2025
PO
500mg
BID
H. Pylori
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes